Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
These initiatives were driven by Baroness Goudie, and are more likely to reflect personal policy preferences.
Baroness Goudie has not introduced any legislation before Parliament
Baroness Goudie has not co-sponsored any Bills in the current parliamentary sitting
Infant feeding is critical to a baby’s healthy growth and development. The Government is committed to giving every child the best start in life, and that includes helping families to access support to feed their baby.
We welcome the Competition and Market Authority’s (CMA) infant formula and follow-on formula market study interim report, and will carefully consider its findings and options. We will continue to engage with the CMA ahead of the publication of its final report in February 2025.
While 2023/24 marked the final year of the Children’s Hospice Grant in its previous format, in 2024/25, NHS England continued to provide an additional £25 million of funding for children and young people’s hospices, maintaining the level of grant funding from 2023/24. For the first time, this funding was transacted by integrated care boards (ICBs), on behalf of NHS England, rather than being centrally administered as before.
The Department and NHS England are aware that the shift to the dissemination of funding via ICBs in 2024/25 has not been as smooth a transition as we would have hoped. However, we are working closely with NHS England to resolve any remaining issues to the 2024/25 funding, and we are also jointly considering the future of this important funding stream beyond 2024/25.
The Minister of State for Care recently met NHS England, Together for Short Lives, and one of the co-chairs of the Children Who Need Palliative Care All-Party Parliamentary Group, Lord Balfe, to discuss children’s palliative and end of life care, and this funding stream was discussed at length at that meeting.
While 2023/24 marked the final year of the Children’s Hospice Grant in its previous format, in 2024/25, NHS England continued to provide an additional £25 million of funding for children and young people’s hospices, maintaining the level of grant funding from 2023/24. For the first time, this funding was transacted by integrated care boards (ICBs), on behalf of NHS England, rather than being centrally administered as before.
The Department and NHS England are aware that the shift to the dissemination of funding via ICBs in 2024/25 has not been as smooth a transition as we would have hoped. However, we are working closely with NHS England to resolve any remaining issues to the 2024/25 funding, and we are also jointly considering the future of this important funding stream beyond 2024/25.
The Minister of State for Care recently met NHS England, Together for Short Lives, and one of the co-chairs of the Children Who Need Palliative Care All-Party Parliamentary Group, Lord Balfe, to discuss children’s palliative and end of life care, and this funding stream was discussed at length at that meeting.
While 2023/24 marked the final year of the Children’s Hospice Grant in its previous format, in 2024/25, NHS England continued to provide an additional £25 million of funding for children and young people’s hospices, maintaining the level of grant funding from 2023/24. For the first time, this funding was transacted by integrated care boards (ICBs), on behalf of NHS England, rather than being centrally administered as before.
The Department and NHS England are aware that the shift to the dissemination of funding via ICBs in 2024/25 has not been as smooth a transition as we would have hoped. However, we are working closely with NHS England to resolve any remaining issues to the 2024/25 funding, and we are also jointly considering the future of this important funding stream beyond 2024/25.
The Minister of State for Care recently met NHS England, Together for Short Lives, and one of the co-chairs of the Children Who Need Palliative Care All-Party Parliamentary Group, Lord Balfe, to discuss children’s palliative and end of life care, and this funding stream was discussed at length at that meeting.
We are committed to creating the healthiest generation of children ever. The child health workforce, including school nurses, who lead the delivery of the Healthy Child Programme is central to how we support children, young people, and families.
We are also committed to training the staff we need to ensure everyone receives care from the right professional, when and where they need it. We will want to assure ourselves, and the National Health Service, that the current workforce plan will deliver the reform needed. We will also need to do this in light of the 10-Year Health Plan.
Local authorities are best placed to determine local workforce needs, as they know their communities best. Determining the skills and workforce requirements should be underpinned by a local plan and led by the area’s identified health needs.
The Chief Public Health Nurse Office has established a programme of work which aims to improve the delivery of the Healthy Child Programme, which includes school nursing. This will include a review of the school nursing workforce data in England.
We are committed to creating the healthiest generation of children ever. The child health workforce, including school nurses, who lead the delivery of the Healthy Child Programme is central to how we support children, young people, and families.
We are also committed to training the staff we need to ensure everyone receives care from the right professional, when and where they need it. We will want to assure ourselves, and the National Health Service, that the current workforce plan will deliver the reform needed. We will also need to do this in light of the 10-Year Health Plan.
Local authorities are best placed to determine local workforce needs, as they know their communities best. Determining the skills and workforce requirements should be underpinned by a local plan and led by the area’s identified health needs.
The Chief Public Health Nurse Office has established a programme of work which aims to improve the delivery of the Healthy Child Programme, which includes school nursing. This will include a review of the school nursing workforce data in England.
Department officials have had a number of conversations with colleagues in NHS England, the National Institute for Health and Care Excellence (NICE), and the Medicines and Healthcare products Regulatory Agency to discuss the progress of key regulatory decisions and the National Health Service's preparations for the adoption of any licensed and NICE recommended treatment for Alzheimer’s disease.
The NICE is currently developing guidance for the NHS on the use of several potential new medicines for the treatment of Alzheimer’s disease, as well as currently consulting on its draft guidance on the use of lecanemab. The NICE has determined that the benefits of this first new treatment are just too small to justify the significant cost to the NHS. These are very difficult decisions to make, and it is right that they are taken independently, and on the basis of the available evidence of costs and benefits. We understand how disappointing the NICE’s draft guidance will be to all those affected, but we need to make sure that the finite resources of the NHS are only spent on treatments that are clinically and cost effective, to ensure patient and taxpayer benefit. The NICE’s draft recommendations are now open to consultation, and the NICE will take the comments received fully into account in developing its final guidance.
Lecanemab is the first disease modifying treatment for Alzheimer’s disease with a marketing approval in Great Britain, and to ensure the health system is prepared for future advances in treatments, a dedicated NHS England team is already looking ahead to 27 other treatments which are currently in advanced clinical trials, that could potentially be approved by 2030.
Ministers and officials regularly engage with women stakeholders, including from across the Middle East and Afghanistan, to ensure our policy and programming reflect their views and needs.
The Minister for the Middle East, North Africa, Afghanistan and Pakistan has hosted Afghan women leaders to hear their perspectives and discuss women's inclusion in Afghanistan's future.
We are aware that the specific needs of marginalised groups, including women, will need to be integrated into planning for recovery in Gaza. Officials engage with both Palestinian and Israeli women-led organisations to seek their views. The UK is steadfast in its commitment to women's participation in conflict resolution and peacebuilding.
Since September 2023, we have committed £18.5 million to the International Organisation for Migration (IOM) to provide emergency assistance to vulnerable returnees in Afghanistan. This support forms part of a broader package of £161 million in assistance to the Afghan people this year. The UK is closely monitoring Pakistan's policy on the deportation of Afghans and has raised the issue on many occasions with the Government of Pakistan. We are working with international partners, including the United Nations Refugee Agency (UNHCR), IOM and the World Bank to ensure Pakistan adheres to its international human rights obligations with respect to those affected.
The Government is committed to working with international partners and businesses to ensure global supply chains are free from human and labour rights abuses. The UK monitors all countries on the Developing Countries Trading Scheme (DCTS) on an ongoing basis for serious and systemic violations of human rights (including gender rights), labour rights and environmental obligations based on international conventions. The DCTS includes the power to suspend a country's preferential tariffs for such violations, however, it does not have the power to individually suspend a company's trade preferences.